Skip to main content
. Author manuscript; available in PMC: 2020 May 11.
Published in final edited form as: J Asthma. 2017 Oct 20;55(9):949–955. doi: 10.1080/02770903.2017.1378357

Table 1.

Baseline characteristics of the study sample before matching.

Total Usual care SDM toolkit
n % n % n % p-value
Total 746 625 83.8 121 16.2
Age, mean (SD) 8.55 4.2 8.52 4.1 8.74 4.5 0.596
Race/ethnicity <0.001
 Caucasian 58 7.8 55 8.8 3 2.5
 African American 404 54.2 338 54.1 66 54.5
 Hispanic/latino 158 21.2 113 18.1 45 37.2
 Other 126 16.9 119 19.0 7 5.8
Insurance 0.105
 Commercial 98 13.1 88 14.1 10 8.3
 Medicaid/other 648 86.9 537 85.9 111 91.7
Gender 0.295
 Male 451 60.5 383 61.3 68 56.2
 Female 295 39.5 242 38.7 53 43.8
Comorbidities
 Obesity 71 9.5 55 8.8 16 13.2 0.035
 Development delay 9 1.2 8 1.3 1 0.8 1.000
 Upper respiratory tract infection 23 3.1 17 2.7 6 5.0 0.243
 Rhinitis 27 3.6 24 3.8 3 2.5 0.601
Baseline ED visits, mean (SD) 0.23 0.6 0.20 0.6 0.39 0.7 0.005
Baseline inpatient visits, mean (SD) 0.14 0.5 0.14 0.5 0.13 0.4 0.821
Baseline oral steroid use, mean (SD) 0.43 0.9 0.42 0.9 0.50 0.9 0.336
Percentage of patients with poverty, mean (SD) 0.24 0.1 0.23 0.1 0.24 0.1 0.654
Percentage of patients with education less than high school, mean (SD) 0.21 0.1 0.21 0.1 0.22 0.1 0.258
Median follow-up (month) 30.45 31.60 27.10 <0.001

Note.

Based on Student’s t-test, Wilcoxon rank sum test, and Chi-square/Fisher’s exact test.

Other includes other public insurance and uninsured.